Portfolio news 0

Oxford Nanopore Technologies Plc

Oxford Nanopore welcomes Wendy Becker and Adrian Hennah to Board

Tissue Regenix Group plc

Completion of phase one of new US facility expansion project

Mirriad Advertising Ltd

Mirriad agrees new commercial terms with Tencent

Xeros Technology Group plc

First license agreement for XFiltra Technology

Microbiotica Ltd

Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology

LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

DeepMatter Group plc

Changes to 2021 AGM Arrangements

Itaconix plc

Notice of Changes to AGM Arrangements and Investor Presentation

Artios Pharma

Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications

DeepMatter Group plc

DeepMatter collaborates with the Universities of Leeds and Sheffield